MarketBeat Daily Ratings for Thursday, January 9, 2025
Ratings changes for Marvell Technology, Tonix Pharmaceuticals, TechTarget, Avadel Pharmaceuticals, T. Rowe Price Group, Vir Biotechnology, OraSure Technologies and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. January 9th, 2025 Today's Top Stories | | By Gabriel Osorio-Mazilli | January 9, 2025 07:45 AM |
| | | By The Associated Press | January 8, 2025 10:53 PM |
| | By Thomas Hughes | January 9, 2025 07:15 AM |
| | | By The Associated Press | January 8, 2025 01:11 PM |
| | By Sam Quirke | January 9, 2025 07:00 AM |
|
|
Analysts' Upgrades | | Globus Medical (NYSE:GMED) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $97.00 price target on the stock, up previously from $80.00. This represents a 12.3% upside from the current price of $86.34. | | Vir Biotechnology (NASDAQ:VIR) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $10.00. This represents a 60.3% upside from the current price of $12.48. |
|
View More Upgrades
|
Analysts' Downgrades | | Harmonic (NASDAQ:HLIT) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $14.00 price target on the stock, down previously from $17.00. This represents a 4.7% upside from the current price of $13.37. |
|
View More Downgrades
|
Analysts' New Coverage | | Cboe Global Markets (NASDAQ:CBOE) is now covered by analysts at William Blair. They set a "market perform" rating on the stock.The current price is $192.99. |
|
View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. | | Start Your 30-Day Free Trial |
| Upgrade Your Subscription | | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | | Upgrade Now |
|
| Manage Your Watchlist | | View and add up to five holdings to your watchlist. | | View My Portfolio |
|
| Join Our Facebook Group | | Join MarketBeat’s free stock discussion and trading idea group on Facebook. | | Join Now |
|
Thank you for subscribing to MarketBeat!We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
© 2006-2025 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States. Today's Bonus Content: Your Free Book for Crypto Bull Run Riches |
